Tandem Diabetes Care (TNDM) Assets (2013 - 2026)

Tandem Diabetes Care's Assets history runs 14 years deep, the most recent figure standing at $1.2 billion for Q1 2026.

• Quarterly Assets rose 25.08% year-over-year to $1.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 billion (up 25.08% YoY) and the FY2025 annual result came in at $881.1 million, down 8.94% from the prior year.
• Assets was $1.2 billion for Q1 2026 at Tandem Diabetes Care, up from $881.1 million in the prior quarter.
• Across five years, Assets topped out at $1.2 billion in Q1 2026 and bottomed at $874.7 million in Q3 2025.
• A 5-year average of $968.0 million and a median of $952.7 million in 2023 frame the typical range for Assets.
• Annual changes were most pronounced in 2022 — Assets jumped 34.6% — and 2023, when it dropped 10.27%.
• Tandem Diabetes Care's Assets stood at $1.1 billion in 2022, then fell by 9.51% to $952.7 million in 2023, then rose by 1.57% to $967.7 million in 2024, then decreased by 8.94% to $881.1 million in 2025, then soared by 30.9% to $1.2 billion in 2026.
• Business Quant data shows TNDM's Assets at $1.2 billion in Q1 2026, $881.1 million in Q4 2025, and $874.7 million in Q3 2025.